EUVIMEDEUVIMED entdecken
EditorialKommentar

Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?

Neil Chanchlani, Richard K Russell

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.18033 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Neil Chanchlani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of paediatric gastroenterology, Bristol Royal Hospital for Children, Bristol, UK. Hauptthemen laut MEDLINE: Infliximab, Crohn Disease, Cost-Benefit Analysis, Gastrointestinal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LINKED CONTENT This article is linked to Vuijk et al papers. To view these articles, visit https://doi.org/10.1111/apt.18000 and https://doi.org/10.1111/apt.18053

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfliximabCrohn DiseaseCost-Benefit AnalysisGastrointestinal AgentsHumansChildAntibodies, Monoclonal

Substanzen

InfliximabGastrointestinal AgentsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of paediatric gastroenterology, Bristol Royal Hospital for Children, Bristol, UK.
  • Exeter Inflammatory Bowel Disease and Pharmacogenetics Group, University of Exeter, Exeter, UK.
  • Department of paediatric gastroenterology, Royal Hospital for Children and Young People, Edinburgh, UK.
  • Child Life and Health, University of Edinburgh, Edinburgh, UK.

Zitieren

APA

Chanchlani, N., & Russell, R. K. (2024). Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18033

Vancouver

Chanchlani N, Russell RK. Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18033

BibTeX
@article{Chanchlani2024,
  author = {Chanchlani, Neil and Russell, Richard K},
  title = {Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.18033}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche